Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03914625
Recruitment Status : Recruiting
First Posted : April 16, 2019
Last Update Posted : May 13, 2022
Information provided by (Responsible Party):
National Cancer Institute (NCI)